Sponsor Pipeline

Kerry Rogers Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
1
Recruiting
2
Disease Areas
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-07-29 NCT07734038 Venetoclax Plus Zanubrutinib for the Treatment of Chronic Lymphocytic Leukemia and Small… Phase 2 Not Yet Recruiting
Active Trials by Phase
Phase 2
2
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT06466122 Pirtobrutinib (LOXO-305) and Venetoclax for the Treatment of Patients With CLL or SLL… Chronic Lymphocytic Leukemia Recruiting
NCT07734038 Venetoclax Plus Zanubrutinib for the Treatment of Chronic Lymphocytic Leukemia and Small… Chronic Lymphocytic Leukemia Not Yet Recruiting
Phase 1/2
NCT02427451 Bcl-2 Inhibitor GDC-0199 in Combination With Obinutuzumab and Ibrutinib in Treating… Chronic Lymphocytic Leukemia Active, Not Recruiting
Disease Areas
Leukemia (3) Chronic Lymphocytic Leukemia (CLL) (3)
Get alerts when Kerry Rogers's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free